Abdominal Obesity Clinical Trial
Official title:
The Effect of Alternating Energy Intake Compared to Regular Energy Intake on the Fat Content in the Blood After a Meal in Abdominally Obese Adults
Increasing evidence suggests that meal timing affects metabolic health. For example, intermittent fasting (IF) may have positive effects on plasma glucose and lipid levels, insulin sensitivity, and blood pressure. However, IF protocols often result in significant weight loss. Therefore, it is not clear to what extent these beneficial metabolic effects are due to IF or to weight loss. Although the effect of IF independent of weight loss has been studied, daily energy intake in those studies did not differ between the days. Therefore, the investigators aim to examine the effect of alternating energy intake - i.e. standardised day-to-day fluctuations in energy intake - on metabolic health independent of weight loss.
Status | Recruiting |
Enrollment | 23 |
Est. completion date | December 2022 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Apparently healthy men and women as judged by study physician - Abdominally obese males (waist circumference = 102 cm) and females (waist circumference = 88 cm) - Aged between 18 - 75 years - Stable bodyweight (weight gain or loss = 3 kg in the past three months) - Willingness to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study - No difficult venipuncture as evidenced during the screening visit - Women should be pre- or postmenopausal - Sedentary (light exercise < 1 h per week) or moderately active (moderate exercise 1-2 h per week) - Having a general practitioner - Agreeing that the participant and general practitioner will be informed about medically relevant personal test results by a physician - Willing to comply to study protocol during study - Informed consent signed Exclusion Criteria: - Fasting plasma glucose = 7 mmol/l - Fasting serum triacylglycerol = 4.5 mmol/l - Fasting serum total cholesterol = 8 mmol/l - Blood pressure = 160/100 mm Hg - Current smoker, or smoking cessation < 12 months - Drug abuse - Alcohol abuse (= 21 alcohol consumptions per week) - Use of medication known to affect blood pressure, serum lipid metabolism, or glucose metabolism - Having a medical condition or history which might impact study measurements, to be judged by the study physician (e.g. myocardial infarction, angina, thrombosis, stroke, cancer, familiar hypercholesterolemia, liver or bowel disease or diabetes) - Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident - Use of an investigational product within another biomedical intervention trial within the previous 1-month - Women who are perimenopausal, have an irregular menstrual cycle, or are pregnant - Use of over-the-counter and prescribed medication, which may interfere with study measurements (to be judged by the principal investigator), e.g. weight loss medication - Reported dietary habits: medically prescribed diets or slimming diets - Reported participation in night shift work 2 weeks prior to screening and/or during the study. Night work is defined as working between midnight and 6.00 AM |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University Medical Center | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | High-Sensitivity C-Reactive Protein (hs-CRP) levels | Fasting hs-CRP as inflammatory marker | Baseline, week 2, and twice in week 4 | |
Other | Blood pressure | Office systolic and diastolic blood pressure | Baseline, week 2, week 3, and twice in week 4 | |
Other | Body weight | Body weight in kilograms | Baseline, week 2, week 3, and twice in week 4 | |
Other | Height | Height in centimeters | Baseline, week 2, week 3, and twice in week 4 | |
Other | Body Mass Index | Body weight and height will be combined to report BMI in kg/m^2 | Baseline, week 2, week 3, and twice in week 4 | |
Other | Waist circumference | Waist circumference in centimeters | Baseline, week 2, week 3, and twice in week 4 | |
Other | Hip circumference | Hip circumference in centimeters | Baseline, week 2, week 3, and twice in week 4 | |
Other | Waist to hip ratio | Waist and hip circumference will be used to report the waist to hip ratio | Baseline, week 2, week 3, and twice in week 4 | |
Primary | Triacylglycerol area under the curve (AUC) | The 4-hour AUC for triacylglycerol after consumption of a standardised mixed meal | 4 hours | |
Secondary | Fasting glucose metabolism | Fasting glucose metabolism (includes e.g. glucose and insulin concentrations) | Baseline, week 2, and twice in week 4 | |
Secondary | Fasting lipid metabolism | Fasting serum lipid and lipoprotein profile | Baseline, week 2, and twice in week 4 | |
Secondary | Marker for postprandial lipid metabolism | Marker for lipid metabolism includes triacylglycerol and will be measured after consumption of a standardised mixed meal | 4 hour period after consumption of a standardised mixed meal | |
Secondary | Markers for postprandial glucose metabolism | Markers for glucose metabolism include insulin and glucose and will be measured after consumption of a standardised mixed meal | 4 hour period after consumption of a standardised mixed meal | |
Secondary | 24-hour glucose levels | The total area under the curve (tAUC) for 24-hour glucose as measured with a continuous glucose sensor | 24 hours | |
Secondary | Day-time glucose levels | The tAUC for day-time glucose (07:00 - 22:00 h) as measured with a continuous glucose sensor | From 07:00 to 22:00 (15 hours) | |
Secondary | Night-time glucose levels | The tAUC for night-time glucose (22:01 - 06:59 h) as measured with a continuous glucose sensor | From 22:01 to 06:59 (8 hours and 58 min) | |
Secondary | Glucose levels after main meal consumption | The tAUC for glucose during 2 hours after main meal consumption (breakfast, lunch and dinner) as measured with a continuous glucose sensor. | 2 hours | |
Secondary | The mean amplitude of glycemic excursions (MAGE) | MAGE as parameter for the assessment of glycemic variability. | 24 hours | |
Secondary | Continuous overall net glycemic action (CONGA) | CONGA to assess intraday glucose variability within predetermined time windows -> 1-hour interval (CONGA-1), 2-hour interval (CONGA-2), and 4-hour interval (CONGA-4). | 1 hour, 2 hours, and 4 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04940962 -
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
|
N/A | |
Completed |
NCT02194504 -
The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity
|
N/A | |
Completed |
NCT00374218 -
Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference
|
Phase 2 | |
Completed |
NCT00520858 -
Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women
|
N/A | |
Recruiting |
NCT03212391 -
WAVE Study- Walking and Aging in VErona Study
|
N/A | |
Completed |
NCT03898518 -
The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls
|
N/A | |
Recruiting |
NCT04136717 -
Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery
|
N/A | |
Completed |
NCT05413954 -
To Evaluate the Health Effect of Particular Fatty Acids Profiles From Eggs
|
N/A | |
Recruiting |
NCT05062954 -
Effects of a Polyphenol-rich Cranberry Extract on Cardiometabolic and Neurocognitive Health
|
N/A | |
Completed |
NCT01472666 -
Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth"
|
N/A | |
Completed |
NCT00990457 -
Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study)
|
Phase 3 | |
Completed |
NCT05685017 -
Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
|
||
Completed |
NCT03773900 -
Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers
|
N/A | |
Completed |
NCT04635332 -
Food Literacy and Physical Activity Intervention to Optimize Metabolic Health Among Women in Urban Uganda
|
N/A | |
Completed |
NCT00739180 -
Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes
|
N/A | |
Completed |
NCT00664729 -
Diet, Exercise, Metabolism, and Obesity in Older Women
|
N/A | |
Completed |
NCT03389425 -
Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study
|
N/A | |
Completed |
NCT05900843 -
Weight Abnormalities With Diet and Exercise Frequency in Egyptian Children With Cerebral Palsy
|
||
Not yet recruiting |
NCT06376955 -
High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity
|
N/A | |
Recruiting |
NCT05879692 -
Response of Irritable Bowel Syndrome to Abdominal Fat Reduction
|
N/A |